Business · 02/10/2019
FDA Announces Public Meeting of Blood Products Advisory Committee
The Food and Drug Administration (FDA) is hosting a public meeting of the Blood Products Advisory Committee (BPAC) to discuss scientific considerations for cold stored platelet products intended for transfusion, and the meeting will be open to the public.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →